Update on PET glucose neuroimaging

Authors: Buchsbaum M. S.; Hazlett E. A.

Source: International Review of Psychiatry, Volume 9, Number 4, 1 December 1997 , pp. 339-354(16)

Publisher: Informa Healthcare

Buy & download fulltext article:

OR

Price: $34.29 plus tax (Refund Policy)

Abstract:

Summary Positron emission tomography with 18F-deoxyglucose yields high-resolution images of brain activity with accurate quantification of a fundamental property of central nervous system function, cerebral glucose metabolic rate. Alone among brain-imaging modalities, the deoxyglucose method can be applied with microscopic resolution in animal studies, permitting detailed comparison of pharmacological response in both human and non-human experiments. In schizophrenia, metabolic imaging has identified functional changes in components of the fronto-striato-thalamic circuits and the temporal lobe, and visualized changes with neuroleptic, anxiolytic and antidepressant treatment.

Language: English

Document Type: Research article

Publication date: 1997-12-01

More about this publication?
Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page